索引于
  • 打开 J 门
  • Genamics 期刊搜索
  • 学术钥匙
  • 期刊目录
  • 研究圣经
  • 中国知网(CNKI)
  • 西马戈
  • 乌尔里希的期刊目录
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-WorldCat
  • SWB 在线目录
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 米亚尔
  • 科学索引服务 (SIS)
  • 欧洲酒吧
  • 谷歌学术
分享此页面
期刊传单
Flyer image

抽象的

Characterization and Evaluation of HepDOCA-doxorubicin Tagged Magnetic Nanoparticles for Hyperthermia

Chandraprabha MN, Lokesh KNL, Rashmi RB, Roshna RG and Vijai SN

This paper reports the hyperemia effect studies of drug-magnetic iron oxide nanoparticle conjugates (MION) for targeted cancer therapy. MIONs were synthesized by the method of co-precipitation using salts of iron as precursors. Chemically modified heparin derivative (heparin deoxycholate, hepDOCA) was complexed to chemotherapeutic drug, doxorubicin (DOX) and tagged to MIONs, which act as the drug-vectors. Each of these conjugates was characterized by SEM and DLS. To observe the effect of formulations, an inductor RF coil circuit was set up which ensured that the MIONs heat up in an AC magnetic field of 0.79 mT at 960 kHz. Hyperthermia treatment was performed on E.coli (DH5-α strain) cells and the growth of bacteria along with the protein released upon cell lysis was monitored. It was confirmed that HepDOCA- DOX-MION complex imparts damage to E.coli cells by the magneto-thermo-cytolysis on application of alternating magnetic field.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证